Objective: The objective is to evaluate the efficacy of using tibial bone marrow delivered to the chondral-bone interface (CBI) via percutaneous chondral bone interface optimization (PeCaBoo) as a therapy for knee osteoarthritis (OA). Study Design: A series of prospective cases were presented. Participants: Our study included 10 patients with medial or lateral compartment knee OA. Methods: With 1 cc of heparin pre-loaded in the syringe, 5 cc of tibial bone marrow was withdrawn from the proximal tibia. The resultant 6 cc of aspirate in the syringe was injected via PeCaBoo, 2 cc at a time, into the superior CBI and inferior CBI. The remaining 2 cc was injected via needle into the intra-articular joint space. Main Outcome Measurements: Patients had MRIs taken pre-procedure and 3 months post-procedure to measure bone edema and intra-articular matrix thickness. Patient-reported outcomes recorded included the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and the Numeric Paint Rating Scale (NRS), which were both obtained pre-procedure and post-procedure at 3, 6, and 12 months. Use of non-steroidal anti-inflammato ries (NSAIDs) was recorded pre- and post-procedure as well. Results: Our study included 4 males and 6 females, with an average age of 63.5 years. The average follow-up time was 14 months, with a range of 13 - 15 months. The mean WOMAC score was 58.2 points pre-procedure and 35.3 points post-procedure (p < 0.01). The mean NRS-Pain score was 8.6 points pre-procedure and 2.8 points post-procedure (p < 0.01). The matrix thickness increased by 14% on average at 3 months post-procedure (p < 0.01). The proportion of patients taking NSAIDs decreased by 60% after the PeCa Boo procedure. The subgroup of patients with tibial edema and knee OA had optimal outcomes . Con clusions: Tibial bone marrow stem cell delivered via PeCaBoo is a novel minimally-invasive treat ment for knee OA, with potential to repair cartilage and improve knee pain and function.
Bhatia, D., Bejarano, T. and Novo, M. (2013) Current Interventions in the Management of Knee Osteoarthritis. Journal of Pharmacy and Bioallied Sciences, 5, 30-38. http://dx.doi.org/10.4103/0975-7406.106561
Goldring, M.B. and Berenbaum, F. (2015) Emerging Targets in Osteoarthritis Therapy. Current Opinion in Pharmacology, 22, 51-63. http://dx.doi.org/10.1016/j.coph.2015.03.004
Naranje, S., Lendway, L., Mehle, S. and Gioe, T.J. (2015) Does Operative Time Affect Infection Rate in Primary Total Knee Arthroplasty? Clinical Orthopaedics and Related Research?, 473, 64-69. http://dx.doi.org/10.1007/s11999-014-3628-4
Brown, N.M., Sheth, N.P., Davis, K., et al. (2012) Total Knee Arthroplasty Has Higher Postoperative Morbidity than Unicompartmental Knee Arthroplasty: A Multicenter Analysis. The Journal of Arthroplasty, 27, 86-90. http://dx.doi.org/10.1016/j.arth.2012.03.022
Farr, J., Tabet, S.K., Margerrison, E. and Cole, B.J. (2014) Clinical, Radiographic, and Histological Outcomes after Cartilage Repair with Particulated Juvenile Articular Cartilage: A 2-Year Prospective Study. American Journal of Sports Medicine, 42, 1417-1425. http://dx.doi.org/10.1177/0363546514528671
Spahn, G., Klinger, H.M. and Hofmann, G.O. (2013) The Effect of Arthroscopic Debridement and Conservative Treatment in Knee Osteoarthritis Results of a 5-Year Follow-Up and Literature Review. Sportverletzung-Sportschaden, 27, 226-231.
Hong, Y.H., Park, C.W., Kim, H.S., Won, K.C., Kim, Y.W. and Lee, C.K. (2013) Effects of Hypoxia/Ischemia on Catabolic Mediators of Cartilage in a Human Chondrocyte, SW1353. Biochemical and Biophysical Research Communications, 431, 478-483. http://dx.doi.org/10.1016/j.bbrc.2013.01.035
Sampson, S., Botto-van Bemden, A. and Aufiero, D. (2015) Regenerative Medicine: Stem Cell Therapies for Treatment of Cartilage and Bone Disorders: Osteoarthritis, Avascular Necrosis, and Non-Union Fractures. PM&R, 7, S26-S32. http://dx.doi.org/10.1016/j.pmrj.2015.01.023
Davies-Tuck, M., Kawasaki, R., Wluka, A.E., et al. (2012) The Relationship between Retinal Vessel Calibre and Knee Cartilage and BMLs. BMC Musculoskeletal Disorders, 13, 255-260. http://dx.doi.org/10.1186/1471-2474-13-255
Matthews, G.L. and Hunter, D.J. (2011) Emerging Drugs for Osteoarthritis. Expert Opinion on Emerging Drugs, 16, 479-491. http://dx.doi.org/10.1517/14728214.2011.576670
Davatchi, F., Abdollahi, B.S., Mohyeddin, M. and Nikbin, B. (2015) Mesenchymal Stem Cell Therapy for Knee Osteoarthritis: 5 Years Follow-Up of Three Patients. International Journal of Rheumatic Diseases, In Press. http://dx.doi.org/10.1111/1756-185X.12670
Wong, K.L., Lee, K.B.L., Lee, E.H., Hui, J.H.P., Law, P. and Tai, B.C. (2013) Injectable Cultured Bone Marrow-Derived Mesenchymal Stem Cells in Varus Knees with Cartilage Defects Undergoing High Tibial Osteotomy: A Prospective, Randomized Controlled Clinical Trial with 2 Years’ Follow-Up. Arthroscopy—Journal of Arthroscopic and Related Surgery, 29, 2020-2028.
Sen, R.K., Tripathy, S.K., Aggarwal, S., Marwaha, N., Sharma, R.R. and Khandelwal, N. (2012) Early Results of Core Decompression and Autologous Bone Marrow Mononuclear Cells Instillation in Femoral Head Osteonecrosis. A Randomized Control Study. Journal of Arthroplasty, 27, 679-686. http://dx.doi.org/10.1016/j.arth.2011.08.008
Narbona-Carceles, J., Vaquero, J., Susana Suárez-Sancho, B.S., Forriol, F. and Fernández-Santos, M.E. (2014) Bone Marrow Mesenchymal Stem Cell Aspirates from Alternative Sources Is the Knee as Good as the Iliac Crest? Injury, 45, S42-S47. http://dx.doi.org/10.1016/S0020-1383(14)70009-9
Smiler, D.G., Soltan, M., Soltan, C. and Matthews, C. (2010) Growth Factors and Gene Expression of Stem Cells: Bone Marrow Compared with Peripheral Blood. Implant Dentistry, 19, 229-240. http://dx.doi.org/10.1097/ID.0b013e3181dc24a9
Fiedler, J., Roderer, G., Günther, K.P. and Brenner, R.E. (2002) BMP-2, BMP-4, and PDGF-bb Stimulate Chemotactic Migration of Primary Human Mesenchymal Progenitor Cells. Journal of Cellular Biochemistry, 87, 305-312. http://dx.doi.org/10.1002/jcb.10309
Sato, N., Beitz, J.G., Kato, J., et al. (1993) Platelet-Derived Growth Factor Indirectly Stimulates Angiogenesis in Vitro. American Journal of Pathology, 142, 1119-1130.
Ferrara, N. (1999) Role of Vascular Endothelial Growth Factor in the Regulation of Angiogenesis. Kidney International, 56, 794-814. http://dx.doi.org/10.1046/j.1523-1755.1999.00610.x
Ribatti, D. (2005) The Crucial Role of Vascular Permeability Factor/Vascular Endothelial Growth Factor in Angiogenesis: A Historical Review. British Journal of Haematology, 128, 303-309. http://dx.doi.org/10.1111/j.1365-2141.2004.05291.x
Ishibashi, H., Nariai, Y., Kanno, T., Onimaru, M. and Sekine, J. (2014) Effects of Transforming Growth Factor Beta 1 on the Plasminogen Activation System, Collagen and Integrin Synthesis, and Proliferation of Rabbit Mandibular Condylar Chondrocytes. International Journal of Oral & Maxillofacial Surgery, 43, 470-475. http://dx.doi.org/10.1016/j.ijom.2013.10.010
Joyce, M.E., Roberts, A.B., Sporn, M.B. and Bolander, M.E. (1990) Transforming Growth Factor-Beta and the Initiation of Chondrogenesis and Osteogenesis in the Rat Femur. Journal of Cell Biology, 110, 2195-2207. http://dx.doi.org/10.1083/jcb.110.6.2195
De Luca, F., Barnes, K.M., Uyeda, J.A., et al. (2001) Regulation of Growth Plate Chondrogenesis by Bone Morphogenetic Protein-2. Endocrinology, 142, 430-436. http://dx.doi.org/10.1210/en.142.1.430
Charalambous, C.P. (2014) Cell Origin and Differentiation in the Repair of Full-Thickness Defects of Articular Cartilage. In: Banaszkiewicz, P.A. and Kader, D.F., Eds., Classic Papers in Orthopaedics, Springer, London, 377-379. http://dx.doi.org/10.1007/978-1-4471-5451-8_95
Chevrier, A., Hoemann, C.D., Sun, J. and Buschmann, M.D. (2007) Chitosan-Glycerol Phosphate/Blood Implants Increase Cell Recruitment, Transient Vascularization and Subchondral Bone Remodeling in Drilled Cartilage Defects. Osteoarthritis and Cartilage, 15, 316-327. http://dx.doi.org/10.1016/j.joca.2006.08.007
Gomoll, A.H., Madry, H., van Dijk, N., et al. (2010) The Subchondral Bone in Articular Cartilage Repair: Current Problems in the Surgical Management. Knee Surgery, Sports Traumatology, Arthroscopy, 18, 434-447. http://dx.doi.org/10.1007/s00167-010-1072-x
“Pain Intensity Instruments”. National Institutes of Health—Warren Grant Magnuson Clinical Center. July 2003. Archived from the Original (PDF) on 9 November 2015.
American College of Rheumatology (2015) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)—General Description. ACR.
Miletic, K.G., Taylor, T.N., Martin, E.T., Vaidya, R. and Kaye, K.S. (2014) Readmissions after Diagnosis of Surgical Site Infection Following Knee and Hip Arthroplasty. Infection Control & Hospital Epidemiology, 35, 152-157. http://dx.doi.org/10.1086/674854
van der Weegen, W., Wullems, J.A., Bos, E., Noten, H. and van Drumpt, R.A. (2015) No Difference between Intra-Articular Injection of Hyaluronic Acid and Placebo for Mild to Moderate Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial. Journal of Arthroplasty, 30, 754-757. http://dx.doi.org/10.1016/j.arth.2014.12.012
Bannuru, R.R., Vaysbrot, E.E., Sullivan, M.C. and McAlindon, T.E. (2014) Relative Efficacy of Hyaluronic Acid in Comparison with NSAIDs for Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Seminars in Arthritis and Rheumatism, 43, 593-599. http://dx.doi.org/10.1016/j.semarthrit.2013.10.002
Ayhan, E., Kesmezacar, H. and Akgun, I. (2014) Intra-Articular Injections (Corticosteroid, Hyaluronic Acid, Platelet Rich Plasma) for the Knee Osteoarthritis. World Journal of Orthopedics, 5, 351-361. http://dx.doi.org/10.5312/wjo.v5.i3.351
Patrício, J.P., Barbosa, J.P., Ramos, R.M., Antunes, N.F. and de Melo, P.C. (2013) Relative Cardiovascular and Gastrointestinal Safety of Non-Selective Non-Steroidal Anti-Inflammatory Drugs versus Cyclo-Oxygenase-2 Inhibitors: Implications for Clinical Practice. Clinical Drug Investigation, 33, 167-183. http://dx.doi.org/10.1007/s40261-013-0052-6
Trelle, S., Reichenbach, S., Wandel, S., et al. (2011) Cardiovascular Safety of Non-Steroidal Anti-Inflammatory Drugs: Network Meta-Analysis. BMJ: British Medical Journal, 342, c7086.
Kazakia, G.J., Kuo, D., Schooler, J., et al. (2013) Bone and Cartilage Demonstrate Changes Localized to Bone Marrow Edema-Like Lesions within Osteoarthritic Knees. Osteoarthritis and Cartilage, 21, 94-101. http://dx.doi.org/10.1016/j.joca.2012.09.008
Wallace, G., Judge, A., Prieto-Alhambra, D., de Vries, F., Arden, N.K. and Cooper, C. (2014) The Effect of Body Mass Index on the Risk of Post-Operative Complications during the 6 Months Following Total Hip Replacement or Total Knee Replacement Surgery. Osteoarthritis and Cartilage, 22, 918-927. http://dx.doi.org/10.1016/j.joca.2014.04.013
Garvin, K.L. and Konigsberg, B.S. (2012) Infection Following Total Knee Arthroplasty: Prevention and Management. Instructional Course Lectures, 61, 411-419.
Murphy, L. and Helmick, C.G. (2012) The Impact of Osteoarthritis in the United States: A Population-Health Perspective: A Population-Based Review of the Fourth Most Common Cause of Hospitalization in US Adults. American Journal of Nursing, 112, S13-S19. http://dx.doi.org/10.1097/01.NAJ.0000412646.80054.21
Whitehouse, J.D., Friedman, N.D., Kirkland, K.B., Richardson, W.J. and Sexton, D.J. (2002) The Impact of Surgical-Site Infections Following Orthopedic Surgery at a Community Hospital and a University Hospital: Adverse Quality of Life, Excess Length of Stay, and Extra Cost. Infection Control and Hospital Epidemiology, 23, 183-189. http://dx.doi.org/10.1086/502033
Waimann, C.A., Fernandez-Mazarambroz, R., Cantor, S.B., et al. (2014) Cost-Effectiveness of Total Knee Replacement: A Prospective Cohort Study. Arthritis Care & Research, 66, 592-599. http://dx.doi.org/10.1002/acr.22186
Aigner, T., Soder, S., Gebhard, P.M., Mc Alinden, A. and Haag, J. (2007) Mechanisms of Disease: Role of Chondrocytes in the Pathogenesis of Osteoarthritis—Structure, Chaos and Senescence. Nature Clinical Practice Rheumatology, 3, 391-399. http://dx.doi.org/10.1038/ncprheum0534
Roman-Blas, J.A. and Jimenez, S.A. (2006) NF-κB as a Potential Therapeutic Target in Osteoarthritis and Rheumatoid Arthritis. Osteoarthritis and Cartilage, 14, 839-848. http://dx.doi.org/10.1016/j.joca.2006.04.008
Noth, U., Steinert, A.F. and Tuan, R.S. (2008) Technology Insight: Adult Mesenchymal Stem Cells for Osteoarthritis Therapy. Nature Clinical Practice Rheumatology, 4, 371-380. http://dx.doi.org/10.1038/ncprheum0816
Caplan, A.I. and Dennis, J.E. (2006) Mesenchymal Stem Cells as Trophic Mediators. Journal of Cellular Biochemistry, 98, 1076-1084. http://dx.doi.org/10.1002/jcb.20886
Pittenger, M.F., Mackay, A.M., Beck, S.C., et al. (1999) Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science, 284, 143-147. http://dx.doi.org/10.1126/science.284.5411.143
Beane, O.S., Darling, E.M., Fonseca, V.C., Cooper, L.L. and Koren, G. (2014) Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal Cells. PLoS ONE, 9, e115963. http://dx.doi.org/10.1371/journal.pone.0115963
Bouquot, J.E., McMahon, R.E. and Glueck, C.J. (2008) Bone Marrow Edema: Mild or Nascent Variant of Ischemic Bone Disease. Journal of Oral and Maxillofacial Surgery, 66, 205-208. http://dx.doi.org/10.1016/j.joms.2007.08.017
Grellier, M., Bordenave, L. and Amédée, J. (2009) Cell-to-Cell Communication between Osteogenic and Endothelial Lineages: Implications for Tissue Engineering. Trends in Biotechnology, 27, 562-571. http://dx.doi.org/10.1016/j.tibtech.2009.07.001